Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

NCT00725322 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00725322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00725322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2007
Completion date
March 31, 2013
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain